73.24
0.83 (1.15%)
| Previous Close | 72.41 |
| Open | 72.30 |
| Volume | 34,231 |
| Avg. Volume (3M) | 51,246 |
| Market Cap | 931,612,928 |
| Price / Earnings (TTM) | 45.49 |
| Price / Earnings (Forward) | 35.59 |
| Price / Sales | 11.74 |
| Price / Book | 9.59 |
| 52 Weeks Range | |
| Earnings Date | 30 Oct 2025 |
| TTM Dividend Yield | 0.90% |
| Profit Margin | 26.33% |
| Operating Margin (TTM) | 27.84% |
| Diluted EPS (TTM) | 1.55 |
| Quarterly Revenue Growth (YOY) | 10.90% |
| Quarterly Earnings Growth (YOY) | 13.30% |
| Total Debt/Equity (MRQ) | 0.07% |
| Current Ratio (MRQ) | 8.87 |
| Operating Cash Flow (TTM) | 26.03 M |
| Levered Free Cash Flow (TTM) | 8.58 M |
| Return on Assets (TTM) | 14.92% |
| Return on Equity (TTM) | 23.81% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | iRadimed Corporation | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -4.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | -1.25 |
|
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 36.83% |
| % Held by Institutions | 58.36% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Nine Ten Capital Management Llc | 30 Jun 2025 | 872,003 |
| Copeland Capital Management, Llc | 30 Jun 2025 | 457,919 |
| Ranger Investment Management, L.P. | 30 Jun 2025 | 214,840 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| SUSI ROGER E. | - | 71.76 | -5,000 | -358,800 |
| Aggregate Net Quantity | -5,000 | |||
| Aggregate Net Value ($) | -358,800 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 71.76 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SUSI ROGER E. | Officer | 06 Oct 2025 | Automatic sell (-) | 5,000 | 71.76 | 358,800 |
| Date | Type | Details |
|---|---|---|
| 02 Sep 2025 | Announcement | IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director |
| 26 Aug 2025 | Announcement | IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference |
| 01 Aug 2025 | Announcement | IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results |
| 25 Jul 2025 | Announcement | IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025 |
| TTM Dividend Yield | 0.90% |
| 3Y Average Dividend Yield | 2.57% |
| Payout Ratio | 40.00% |
| Expected Next Dividend Payment | Nov 2025 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 18 Aug 2025 | 31 Jul 2025 | 28 Aug 2025 | 0.17 Cash |
| 20 May 2025 | 05 May 2025 | 30 May 2025 | 0.17 Cash |
| 24 Feb 2025 | 06 Feb 2025 | 05 Mar 2025 | 0.17 Cash |
| 15 Nov 2024 | 30 Oct 2024 | 25 Nov 2024 | 0.15 Cash |
| 20 Aug 2024 | 31 Jul 2024 | 30 Aug 2024 | 0.15 Cash |
| 17 May 2024 | 02 May 2024 | 30 May 2024 | 0.15 Cash |
| 21 Dec 2023 | 07 Dec 2023 | 12 Jan 2024 | 0.63 Cash |
| 10 Feb 2023 | 01 Feb 2023 | 21 Feb 2023 | 1.05 Cash |
| 16 Feb 2022 | 07 Feb 2022 | 24 Feb 2022 | 1 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.510 | 3 | 0.70 |
| 2024 | 1.08 | 4 | 1.96 |
| 2023 | 1.05 | 1 | 2.21 |
| 2022 | 1.00 | 1 | 3.54 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |